Search research articles
Contact Us
Filters
Showing results (171-180 of 182) with videos related to
Page
of 19
Sort By:
Rheumatology (Oxford, England)
|
November 23, 2019
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
Isabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Nature Medicine
|
October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Eclinicalmedicine
|
June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Nature Medicine
|
November 27, 2023
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine
|
January 3, 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Medicine
|
May 7, 2014
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin
Yves Allenbach, Laurent Drouot, Aude Rigolet, et al.
Journal of the American Academy of Dermatology
|
November 14, 2020
Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients
Elina Zuelgaray, Sylvie Chevret, Marie Jachiet, et al.
Cancer Discovery
|
February 23, 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
Neurology
|
June 4, 2020
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases
Yves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, et al.
RMD Open
|
November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 182) with videos related to
Sort By:
Page
of 19
Rheumatology (Oxford, England)
|
November 23, 2019
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
Isabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
Nature Medicine
|
October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Eclinicalmedicine
|
June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Nature Medicine
|
November 27, 2023
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine
|
January 3, 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Medicine
|
May 7, 2014
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin
Yves Allenbach, Laurent Drouot, Aude Rigolet, et al.
Journal of the American Academy of Dermatology
|
November 14, 2020
Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients
Elina Zuelgaray, Sylvie Chevret, Marie Jachiet, et al.
Cancer Discovery
|
February 23, 2023
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, et al.
Neurology
|
June 4, 2020
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases
Yves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, et al.
RMD Open
|
November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Page
of 19